Similar to the MC38 model, the anti-PD-1 vaccine combination (PVAX) significantly reduced B16-F10 as well as CT26 tumor growth and prolonged survival in SFD- and HFD-fed mice (Fig. 5, F–H; and Fig. S4, A–C). The gene discussed is DDX53; the disease is neoplasm.